PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1844291
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1844291
The Latin America Pet Therapeutic Diet Market was valued at USD 337.8 million in 2024 and is estimated to grow at a CAGR of 8% to reach USD 714.9 million by 2034.
This consists of specially formulated diets tailored to address specific medical conditions in pets, such as gastrointestinal problems, diabetes, kidney disease, skin issues, and urinary tract disorders. These diets go beyond general pet food and are typically recommended by veterinary professionals as part of a treatment plan. As pet owners increasingly consider animals as family members, attention to nutrition and preventive care has surged across the region. The shift has been particularly notable since the pandemic, when stronger emotional bonds with pets emerged. While veterinary clinics remain a key distribution channel, availability has expanded significantly through online platforms and specialty retail stores, making therapeutic pet diets more accessible than ever before. This increased reach is accelerating awareness and adoption among pet parents.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $337.8 Million |
Forecast Value | $714.9 Million |
CAGR | 8% |
The dry food segment generated USD 198.3 million in 2024. Dry therapeutic diets are widely preferred due to their affordability, long shelf life, and ease of handling and storage. These diets are available in a variety of formulas targeting common health conditions such as weight gain, digestive sensitivity, skin irritation, and chronic renal issues. The convenience of dry food formats, combined with their availability across retail chains, veterinary outlets, and online stores, continues to support their dominance in Latin America's market. These factors make dry diets a reliable option for pet owners focused on both nutrition and convenience.
In 2024, the dogs segment held a 67.1% share, driven by their larger population and more frequent occurrences of chronic conditions compared to other companion animals. Dogs are more prone to obesity, arthritis, allergies, and gastrointestinal issues, all of which require tailored diets for effective management. Given their higher caloric intake needs due to larger body size, therapeutic diets for dogs often involve greater volumes of food, further increasing revenue in this segment. As more dog owners pursue veterinarian-guided nutrition plans, demand for targeted diet solutions continues to grow.
Brazil Pet Therapeutic Diet Market generated USD 137.8 million in 2024, supported by high levels of pet ownership and a strong network of veterinary services. Additionally, a growing incidence of pet health issues particularly obesity, allergies, and digestive disorders is driving interest in veterinary-prescribed nutrition. Therapeutic diets are now being used not only as treatment but also as preventive healthcare tools by a rising number of pet owners. As a result, Brazil continues to lead regional adoption trends in the segment.
Key players operating in the Latin America Pet Therapeutic Diet Industry include Farmina Pet Foods, VNG, Virbac, Stella and Chewy's, Champion Petfoods, Affinity Petcare, Animonda, Hill's Pet Nutrition (Colgate Palmolive), Mars, Incorporated, Blue Buffalo (General Mills), Diamond Pet Foods (Schell & Kampeter, Inc.), and Purina PetCare (Nestle SA). To strengthen their position in the Latin America pet therapeutic diet market, leading companies are actively expanding product lines tailored to region-specific health conditions. They are also investing in partnerships with veterinary clinics to build brand trust among professionals. Companies are leveraging digital platforms for wider distribution and consumer education. Local manufacturing is being scaled to reduce logistics costs and ensure product freshness.